| Dr Marissa Lynne Borrello, PSYD | |
|
1325 Wyoming Blvd Ne, Albuquerque, NM 87112-5046 | |
| (505) 291-5300 | |
| Not Available |
| Full Name | Dr Marissa Lynne Borrello |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 14 Years |
| Location | 1325 Wyoming Blvd Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023484755 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 1200 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Presbyterian Hospital | Albuquerque, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Presbyterian Healthcare Services | 9234041708 | 1099 |
News Archive
According to a new review, approximately 30 million Americans – about 15 percent of adults – have chronic kidney disease, a number that is expected to increase in the next 20 years due to rising obesity rates and longer lifespans, but the majority of chronic kidney disease patients aren't receiving potentially lifesaving treatment.
Pharmaceutical companies are focusing on more unique approaches in the development of educational and experiential solutions for their health care customers at medical conferences, according to Joe Scrocco, chief executive officer of OneWorld, Inc., a leading pharmaceutical consulting firm.
In collaboration with the peer-led organization Survivors' Voices, researchers from King's School of Life Course Sciences have launched a charter to guide organizations and individuals to safely and meaningfully engage abuse survivors in health and social care research.
The case of Sen. Edward Kennedy (D-Mass.), who has been diagnosed with brain cancer, is "identical from a regulatory standpoint to the plight of hundreds of thousands of other Americans" and "shouts to the heavens the humane necessity of urgent reform in the drug approval process to make it work better for people who have serious and terminal diseases," according to a Wall Street Journal opinion piece by Steven Walker and Ronald Trowbridge, chief adviser and adjunct scholar, respectively, of the Abigail Alliance for Better Access to Developmental Drugs.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its new molecular amplification assay, illumigene™ C. difficile. Clostridium difficile is a bacterium that can cause diarrhea and, in severe cases, a life-threatening inflammation of the colon.
› Verified 6 days ago
| Entity Name | Presbyterian Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104802354 PECOS PAC ID: 9234041708 Enrollment ID: O20031103000603 |
News Archive
According to a new review, approximately 30 million Americans – about 15 percent of adults – have chronic kidney disease, a number that is expected to increase in the next 20 years due to rising obesity rates and longer lifespans, but the majority of chronic kidney disease patients aren't receiving potentially lifesaving treatment.
Pharmaceutical companies are focusing on more unique approaches in the development of educational and experiential solutions for their health care customers at medical conferences, according to Joe Scrocco, chief executive officer of OneWorld, Inc., a leading pharmaceutical consulting firm.
In collaboration with the peer-led organization Survivors' Voices, researchers from King's School of Life Course Sciences have launched a charter to guide organizations and individuals to safely and meaningfully engage abuse survivors in health and social care research.
The case of Sen. Edward Kennedy (D-Mass.), who has been diagnosed with brain cancer, is "identical from a regulatory standpoint to the plight of hundreds of thousands of other Americans" and "shouts to the heavens the humane necessity of urgent reform in the drug approval process to make it work better for people who have serious and terminal diseases," according to a Wall Street Journal opinion piece by Steven Walker and Ronald Trowbridge, chief adviser and adjunct scholar, respectively, of the Abigail Alliance for Better Access to Developmental Drugs.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its new molecular amplification assay, illumigene™ C. difficile. Clostridium difficile is a bacterium that can cause diarrhea and, in severe cases, a life-threatening inflammation of the colon.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marissa Lynne Borrello, PSYD 1325 Wyoming Blvd Ne, Albuquerque, NM 87112-5046 Ph: () - | Dr Marissa Lynne Borrello, PSYD 1325 Wyoming Blvd Ne, Albuquerque, NM 87112-5046 Ph: (505) 291-5300 |
News Archive
According to a new review, approximately 30 million Americans – about 15 percent of adults – have chronic kidney disease, a number that is expected to increase in the next 20 years due to rising obesity rates and longer lifespans, but the majority of chronic kidney disease patients aren't receiving potentially lifesaving treatment.
Pharmaceutical companies are focusing on more unique approaches in the development of educational and experiential solutions for their health care customers at medical conferences, according to Joe Scrocco, chief executive officer of OneWorld, Inc., a leading pharmaceutical consulting firm.
In collaboration with the peer-led organization Survivors' Voices, researchers from King's School of Life Course Sciences have launched a charter to guide organizations and individuals to safely and meaningfully engage abuse survivors in health and social care research.
The case of Sen. Edward Kennedy (D-Mass.), who has been diagnosed with brain cancer, is "identical from a regulatory standpoint to the plight of hundreds of thousands of other Americans" and "shouts to the heavens the humane necessity of urgent reform in the drug approval process to make it work better for people who have serious and terminal diseases," according to a Wall Street Journal opinion piece by Steven Walker and Ronald Trowbridge, chief adviser and adjunct scholar, respectively, of the Abigail Alliance for Better Access to Developmental Drugs.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its new molecular amplification assay, illumigene™ C. difficile. Clostridium difficile is a bacterium that can cause diarrhea and, in severe cases, a life-threatening inflammation of the colon.
› Verified 6 days ago
Dr. Cynthia A. Ziemer, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 301 Unser Blvd Nw, Albuquerque, NM 87121 Phone: 505-925-4126 | |
Dr. Michael Carvajal, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 915 Vassar Dr Ne Ste 170, Albuquerque, NM 87106 Phone: 505-272-8833 Fax: 505-272-8316 | |
Dr. William Gary Mcfarland, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4801 Indian School Rd Ne Ste 200, Albuquerque, NM 87110 Phone: 505-875-7357 Fax: 505-286-7442 | |
Dr. Joseph Alfred Bousquet, MSW, PHD Psychologist Medicare: Medicare Enrolled Practice Location: One San Rafael, The Cognitive Behavorial Institute Of Albuquerque, Albuquerque, NM 87122 Phone: 505-832-1600 Fax: 505-832-1161 | |
Dr. Helen Lamar Jackson, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6000 Summer Ave Ne, Albuquerque, NM 87110 Phone: 505-266-4226 Fax: 505-265-3844 | |
Dr. Gary J Neuger, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4801 Lang Ave Ne Ste 110, Albuquerque, NM 87109 Phone: 505-798-2552 | |
Dr. Bryan Lance Hurt, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3405 Pan American Fwy Ne, Albuquerque, NM 87107 Phone: 505-222-0324 Fax: 505-222-0301 |